Abstract:Background Postoperative seroma formations are one of the most common and serious complications after implant-based breast reconstruction and can lead to implant and thus breast loss. The cause hasn`t yet been clarified. Hypothesis generating and thus as a basis for this multicenter study is the suspicion of a connection between immunological-inflammatory processes that promote the development of a seroma. First promising results of the pilot phase (SerMa pilot) have been published and gave the first impulse for this study. Trial design The SerMa (EUBREAST 5) study is a prospective, multicenter, interventional, international study including patients with primary breast cancer and a skin-/nipple-sparing mastectomy combined with an implant-based reconstruction method. Control groups were chosen to work out common group-specific differences. Intra- or directly preoperatively collected blood as well as intraoperatively collected local smear using swabs are preserved specimens. Follow-up includes visits after 2 and 6 weeks as well as after 6 months. In case of a seroma formation fluid aspirations are preserved for laboratory analyses. Eligibility criteria: The study population contains patients with primary diagnosis of breast cancer scheduled for skin-/nipple-sparing mastectomy and implant-based breast reconstruction. The three control groups are: one with simple mastectomy without breast reconstruction as well as healthy persons with implant insert but without breast cancer after bilateral risk reducing mastectomy or last in case of purely cosmetic implant placement. Specific aims: The main objective of the study is to identify a patient subgroup with an increased risk of seroma development for future precision elucidation regarding the prevention of postoperative complications such as implant and thus breast loss. FACS-/Bioplex and microbiome analyses will be applied for the detection of certain immune markers, microbiobes and microbiome diversity using preoperative blood samples, intraoperative local smear collection and in case of later seroma formations also postoperative seroma aspirations. Secondary endpoints include the comparison of these factors and elaborate differences between study and control groups. Furthermore clinico-pathological factors as well as different surgical methods are compared. Statistical methods: A statistical plan for this analysis was specifically developed (Power analyses with Wilcoxon-Mann-Whitney test) and leads to a number of 300 participants per group. Target accrual: Planned start: Q1/2023 Contact: EUBREAST e.V. Citation Format: Nina Ditsch, Nicole Pochert, Udo Jeschke, Mariella Schneider, Melitta Koepke, Maggie Banys-Paluchowski, Claudia Traidl-Hoffmann, Christian Dannecker, Thorsten Kühn. SerMa – Seroma formations of the Mammary gland in breast cancer patients after mastectomy and implant-based reconstruction (EUBREAST 5) [abstract]. In: Proceedings of the 2022 San Antonio Breast Cancer Symposium; 2022 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2023;83(5 Suppl) nr OT3-20-04.

Seroma incidence and risk factors in women undergoing mastectomies as surgical breast cancer treatment

Seroma Formation after Breast Cancer Surgery and Its Risk Factors.

Risk Factors for Postoperative Seromas in Chinese Breast Cancer Patients.

Outcomes and complications of postoperative seroma cavities following soft-tissue sarcoma resection

[Complications and incidents associated with arm edema in the first 3 months after mastectomy]

Risk factors for postoperative seromas in Chinese breast cancer patients

Relationship Between Seroma Formation after Operation of Breast Cancer with Comorbidity of Internal Diseases and Patients' Characteristics:A Clinical Study

Abstract OT3-20-04: SerMa – Seroma formations of the Mammary gland in breast cancer patients after mastectomy and implant-based reconstruction (EUBREAST 5)

Daily Serum Collection after Acellular Dermal Matrix-Assisted Breast Reconstruction

Efficacy of axillary dead space closure after mastectomy, axillary clearance and prosthetic reconstruction: a single-center preliminary experience

Prior Caesarean Section Delivery Increases the Risk for Seroma Development in Abdominoplasty Patients: Our Experience With 746 Patients

Seroma formation after mastectomy: A systematic review and network meta‐analysis of different flap fixation techniques

A quilting sutures technique for flap closure in patients undergoing modified radical mastectomy for the prevention of seroma: A single-center, randomized controlled trial

Risk factors and clinical impact of seroma formation following laparoscopic inguinal hernia repair: a retrospective study

Quilting following mastectomy reduces seroma, associated complications and health care consumption without impairing patient comfort

Animal models for preventing seroma after surgery: a systematic review and meta-analysis

Seroma control in axillary lymphadenectomy with Glubran 2® without drain. Multicenter, prospective, randomized, clinical trial. GALA-ND study (Glubran, Axillary Lymphadenectomy, Ambulatory, No Drain)

PRELIMINARY EVALUATION ON SEROMA PREVENTION AND TREATMENT WITH TRANSPOSITION OF TISSUE FLAPS AND ARISTA HEMOSTATIC POWDER

Immediate prepectoral versus submuscular breast reconstruction in nipple-sparing mastectomy: a retrospective cohort analysis

An efficient technique for drainage of seromas after breast cancer surgery

Incidence and Risk Factors for Venous Thromboembolism in Female Patients Undergoing Breast Surgery